PR PolyResearch
Join Free
NASDAQ

Revolution Medicines, Inc. - Warrant (RVMDW)

♥ 586 Thanks from members

Revolution Medicines, Inc. - Warrant (RVMDW) trades near $11.80–$12.36 against a volatile backdrop, driven by positive oncology pipeline progress, FDA filings for daraxonrasib, and institutional rebalancing despite wider-than-anticipated Q2 2026 losses and non-cash warrant valuation charges.

No chart available for this instrument.
Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →

Other Nasdaq Tickers

NASDAQ
GraniteShares 2x Long AAPL Daily ETF (AAPB)
NASDAQ
Apple Inc. (AAPL)
NASDAQ
Direxion Daily AAPL Bear 1X ETF (AAPD)
NASDAQ
Ascentage Pharma Group International - American Depository Shares (AAPG)
NASDAQ
Direxion Daily AAPL Bull 2X ETF (AAPU)
NASDAQ
Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)